Isabelle Vitali News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Isabelle vitali. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Isabelle Vitali Today - Breaking & Trending Today

Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class .
NovadiscoveryFebruary 16, 2021 GMT
NOVA to develop COVID-19 disease model to support Sanofi’s vaccine and therapeutic efforts 
Lyon, France – 16 February 2021: Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has raised €2.5 million in a Series A2 financing round from Sanofi.
The funds will be used to advance NOVA’s
in silico clinical trial simulation platform, JINKO; to facilitate the Company’s expansion into the US; and develop a COVID-19 disease model in collaboration with Sanofi. JINKO’s workflows are designed to closely resemble those of real life clinical studies and it offers an integrated s ....

Henri Boissel , Carina Jurs , Melissa Gardiner , Isabelle Vitali , Sukaina Virji , Olivier Bogillot , Consilium Strategic Communications , Global Head , Digital Innovation , Sanofi France , Chief Executive Officer , Public Health , Products And Services , Coronavirus Pandemic , Product Testing , Globe Newswire , Pharmaceutical Manufacturing , Health Care Industry , Lung Disease , Covid 19 Pandemic , Medical Research , Drug Trials , Clinical Trials , Western Europe , Infectious Diseases , New Product Development ,

Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform


Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform
NOVA to develop COVID-19 disease model to support Sanofi s vaccine and therapeutic efforts
Lyon, France - 16 February 2021: Novadiscovery ( NOVA ), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has raised €2.5 million in a Series A2 financing round from Sanofi.
The funds will be used to advance NOVA s
in silico clinical trial simulation platform, JINKO; to facilitate the Company s expansion into the US; and develop a COVID-19 disease model in collaboration with Sanofi. JINKO s workflows are designed to closely resemble those of real life clinical studies and it offers an integrated suite of applications from Discovery to Market Access. ....

Henri Boissel , Carina Jurs , Melissa Gardiner , Isabelle Vitali , Sukaina Virji , Olivier Bogillot , Consilium Strategic Communications , Global Head , Digital Innovation , Sanofi France , Chief Executive , கரினா ஜூர்ஸ் , மெலிசா தோட்டக்காரர் , இசபெல் உயிர் , கொன்சில்ிும் மூலோபாய தகவல்தொடர்புகள் , உலகளாவிய தலை , டிஜிட்டல் கண்டுபிடிப்பு , சனோஃபி பிரான்ஸ் , தலைமை நிர்வாகி ,

Union sacrée pour promouvoir les initiatives dans la santé

Union sacrée pour promouvoir les initiatives dans la santé
lefigaro.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lefigaro.fr Daily Mail and Mail on Sunday newspapers.

Isabelle Vitali , Joe Biden , இசபெல் உயிர் , ஓஹோ பிடென் ,